|
|
|
|
Chronic unpredictable stress-induced reduction in the hippocampal brain-derived neurotrophic factor (BDNF) gene expression is antagonized by zinc treatment
|
|
|
|
|
|
|
|
نویسنده
|
cieśelik k. ,sowa-kućma m. ,ossowska g. ,legutko b. ,wolak m. ,opoka w. ,nowak g.
|
|
منبع
|
pharmacological reports - 2011 - دوره : 63 - شماره : 2 - صفحه:537 -543
|
|
چکیده
|
Preclinical data indicate the antidepressant activity of zinc and the involvement of the brain-derived neurotrophic factor (bdnf) in this mechanism. the present study investigates the effect of chronic (16 days) combined treatment with zinc (15 mg/kg zinc hydroaspartate) and imipramine (5 mg/kg) in chronic unpredictable stress (cus) on the bdnf mrna level in the rat brain. moreover,serum zinc concentrations were also assessed. cus induced a significant reduction in the bdnf mrna level in the hippocampus by 21% but had no effect in the frontal cortex. repeated treatment with zinc induced a significant increase in the bdnf mrna level in the hippocampus in the unstressed animals by 12% and as in the chronically stressed animals by 14%,compared to the appropriate controls. imipramine treatment did not affect this factor. however,combined treatment of zinc and imipramine induced a 12% elevation of the bdnf mrna level in the stressed but not in the unstressed rats. cus induced a 19% reduction in the serum zinc concentration,whereas combined treatment of zinc and imipramine reduced this concentration by 24% in the unstressed and increased it (by 20%) in the stressed animals. these results indicate that: 1) cus induces a reduction in the bdnf gene expression with a concomitant diminution of serum zinc concentration and 2) the cus-induced reduction in the bdnf gene expression is antagonized by chronic treatment with zinc. copyright © 2011 by institute of pharmacology polish academy of sciences.
|
|
کلیدواژه
|
BDNF; Chronic treatment; Chronic unpredictable stress; Imipramine; Zinc
|
|
آدرس
|
department of experimental and clinical pharmacology,medical university of lublin,jaczewskiego 8,pl 20-090 lublin, Poland, department of behavioral neuroscience and drug development,institute of pharmacology,polish academy of sciences,smȩtna 12,pl 31-343 kraków, Poland, department of experimental and clinical pharmacology,medical university of lublin,jaczewskiego 8,pl 20-090 lublin, Poland, department of neurobiology,institute of pharmacology,polish academy of sciences,smȩtna 12,pl 31-343 kraków,poland,department of psychiatry and human behavior,university of mississippi medical center,2500 n. state st.,box 127,jackson,ms 39216-4505, United States, department of pharmacobiology,jagiellonian university medical college,medyczna 9,pl 30-688 kraków, Poland, department of inorganic chemistry,jagiellonian university medical college,medyczna 9,pl 30-688 kraków, Poland, department of neurobiology,institute of pharmacology,polish academy of sciences,smȩtna 12,pl 31-343 kraków,poland,department of pharmacobiology,jagiellonian university medical college,medyczna 9,pl 30-688 kraków, Poland
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Authors
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|